Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel ...

Bryan Johnson challenges the inevitability of decay and death, advocating for a different approach to life and longevity.

Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia TOKY ...

Iowa has the second highest incidence rate of cancer in the country, and it is already feeling Trump's cuts to the workforce ...

Q4 2024 Earnings Call Transcript March 4, 2025 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.8, expectations were $0.3. Operator: Greetings, and welcome to Rigel ...

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble ...

The Bureau of Animal Industry (BAI) is refining the guidelines on the bilateral recognition of bird flu regionalization to ...

With defocus contact lenses on the market, research into future myopia management techniques narrow in on defocus spectacles ...

Wildlife officials are looking into a report of 20 dead ducks, geese and seagulls on a community beach in East Patchogue ...

A cluster of deaths linked to a mysterious illness in the Democratic Republic of the Congo could be the result of a poisoning ...

Heart attacks and strokes rise exponentially with age and make a major contribution to increasing healthcare costs and lost productivity. In the UK more than 7 million people are living with ...

Urinary tract infections (UTIs) are common in older adults due to age-related risk factors and can often cause symptoms that ...